CA
DPLO

Continental Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Continental Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-42,800
Closed -$859K – 111
2017
Q4 		$859K Hold
42,800
– – 0.19% 92
2017
Q3 		$886K Buy
42,800
+10,000
+30% +$169K 0.2% 89
2017
Q2 		$485K Buy
+32,800
New +$547K 0.11% 120

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Continental Advisors's DPLO Position: Q1 2018 in Review

Continental Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 42,800 shares — an estimated $859K sold.

Continental Advisors first reported a position in DPLO in Q2 2017 and held it in 3 quarters. The position peaked at $886K in Q3 2017. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • Continental Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • Continental Advisors sold 42,800 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $859K.
  • Continental Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 3 quarters.
  • Continental Advisors's DIPLOMAT PHARMACY, INC. position peaked at $886K in Q3 2017.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Continental Advisors's 13F filing for Q1 2018, filed 14 May 2018.